BALTIMORE, April 29 /PRNewswire/ -- Ameritox, the nation's leader in pain prescription monitoring, announced today that they have entered into an agreement with Aetna to offer Aetna's network of providers nationwide with easy access to Ameritox's pain medication monitoring process.
Ameritox's patented Rx Guardian(SM) methodology is the only pain medication monitoring process that uses a patented methodology to help physicians assess whether patients are taking their pain medication consistent with the prescribed dosage. Ameritox provides physicians and other prescribers with valuable information and a wide range of tools to help them better manage their patients' chronic pain and to help mitigate risks associated with non-compliance, diversion and more.
Under the agreement, Ameritox will provide laboratory analyses for a broad range of drugs and metabolites using state-of-the-art equipment, such as multiplexing liquid chromatography-tandem mass spectrometry (LC/MS/MS); the patented Rx Guardian methodology, which compares expected ranges to a normalized value based upon each patient's prescription regimen and other individual data; detailed Rx Guardian Reports that not only indicate in-range and out-of-range results, but also include a toxicologist's explanation of the potential sources of detected compounds; and a Toxicology Hotline offering individual consultations to prescribers.
Ameritox is the nation's leader in pain prescription drug monitoring, processing thousands of specimens everyday. Only Ameritox offers the Rx Guardian(SM) Report, the most thorough and personalized lab report available and the only report that uses a proprietary methodology to help physicians assess whether patients are taking their pain medication consistent with the dosage prescribed by their physicians. By comparing normalized values to expected prescription-specific ranges, Rx Guardian assists pain practitioners in protecting their patients by providing information to help them assess compliance based on prescription regimens. Rx Guardian also provides peace of mind to physicians and protection to their practices by providing data to help ensure that patients are taking pain medications as prescribed. Headquarters are located in Baltimore, MD, and laboratory facilities in Midland, TX. For additional information, please contact us by phone at 866-926-9264, by email at firstname.lastname@example.org, or visit us at http://www.ameritox.com.
AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.
For more information, contact: Jennifer Paganelli Edelman 212-642-7774 email@example.com
Copyright©2009 PR Newswire.
All rights reserved